TY  - JOUR
AU  - Jončić-Savić, Katarina
AU  - Pešić, Jelena
AU  - Rajić, Mirjana
AU  - Lukić, Milica
AU  - Jakšić, Ivana
AU  - Milić, Jela
AU  - Vuleta, Gordana
AU  - Savić, Snežana
PY  - 2010
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1443
AB  - In recent years there has been a growing interest for the development and characterization of vehicles for active pharmaceutical ingredients (API) for semisolid dosage forms. Considering that research efforts applied on the new APIs are time consuming and costly, one of the approaches for advancement of therapies of skin and mucous tissue diseases or therapies for muscle and joint pain is focused on the modification of the existing formulations and development and characterization of new vehicles for APIs. The aim of this study was to evaluate the effect of variation of different factors of formulation such as type and concentration of gelling agents, concentration of isopropyl alcohol (IPA) as a solvent and as a penetration enhancer, physicochemical properties of the active substance (ketoprofen) obtained from different manufacturers, on properties and stability of hydrophilic gel with 2.5% m/m ketoprofen. Characterization of prepared samples was done through physicochemical, biopharmaceutical investigation and stability testing. Results obtained suggest satisfactory physicochemical stability of investigated samples as well as the formulation factors which have the most effect on physicochemical properties of ketoprofen gel product: the type of gelling agent followed by the concentration of the gelling agent, while the IPA concentration has the least effect (in the investigated range). Comparison of release profiles of the investigated formulations of carbomer gels did not show significant effect of the varied factors (concentration of the gelling agent and IPA) on ketoprofen release.
AB  - Poslednjih godina se sve više pažnje posvećuje razvoju i karakterizaciji podloga kao nosača lekovitih supstanci (aktivni farmaceutski sastojak, eng. API) u farmaceutskim oblicima polučvrste konzistencije za primenu na koži ili sluzokoži. S obzirom da ispitivanja novih lekovitih supstanci zahtevaju velika ulaganja i dugo traju, jedan od pristupa unapređenja terapije bolesti kože, sluzokože ili bolova u mišićima i zglobovima, usmeren je ka modifikaciji postojećih podloga i razvoju i karakterizaciji novih nosača lekovitih supstanci. Cilj rada je bio da se ispita uticaj variranja različitih faktora formulacije kao što su tip i koncentracija sredstva za geliranje, koncentracija izopropil alkohola (IPA) kao rastvarača i 'pojačivača'/inhensera penetracije, fizičkohemijske karakteristike uzoraka aktivne supstance (ketoprofen), nabavljenih od različitih proizvođača, na osobine i stabilnost hidrofilnog gela sa 2,5% (m/m) ketoprofena. Karakterizacija pripremljenih uzoraka ketoprofen gela sprovedena je kroz fizičkohemijska i biofarmaceutska ispitivanja i ispitivanje stabilnosti. Dobijeni rezultati ukazuju na zadovoljavajuću stabilnost ispitivanih uzoraka, kao i na to da faktori formulacije koji ispoljavaju najveći uticaj na fizičkohemijske karakteristike preparata ketoprofen gela jesu: tip upotrebljenog gelirajućeg sredstva, zatim koncentracija korišćenog sredstva za geliranje, a najmanji uticaj ima koncentracija IPA (u ispitivanom opsegu). Poređenjem profila oslobađanja lekovite supstance iz ispitivanih formulacija karbomernih gelova, nije zapažen značajan uticaj variranih faktora (koncentracije gelirajućeg sredstva i IPA) na oslobađanje ketoprofena.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - The influence of different formulation factors on physicochemical and biopharmaceutical characteristics of ketoprofen 2,5% gel
T1  - Uticaj faktora formulacije na fizičkohemijske i biofarmaceutske karakteristike ketoprofen 2,5% gela
VL  - 60
IS  - 6
SP  - 1237
EP  - 1255
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1443
ER  - 

@article{
author = "Jončić-Savić, Katarina and Pešić, Jelena and Rajić, Mirjana and Lukić, Milica and Jakšić, Ivana and Milić, Jela and Vuleta, Gordana and Savić, Snežana",
year = "2010",
abstract = "In recent years there has been a growing interest for the development and characterization of vehicles for active pharmaceutical ingredients (API) for semisolid dosage forms. Considering that research efforts applied on the new APIs are time consuming and costly, one of the approaches for advancement of therapies of skin and mucous tissue diseases or therapies for muscle and joint pain is focused on the modification of the existing formulations and development and characterization of new vehicles for APIs. The aim of this study was to evaluate the effect of variation of different factors of formulation such as type and concentration of gelling agents, concentration of isopropyl alcohol (IPA) as a solvent and as a penetration enhancer, physicochemical properties of the active substance (ketoprofen) obtained from different manufacturers, on properties and stability of hydrophilic gel with 2.5% m/m ketoprofen. Characterization of prepared samples was done through physicochemical, biopharmaceutical investigation and stability testing. Results obtained suggest satisfactory physicochemical stability of investigated samples as well as the formulation factors which have the most effect on physicochemical properties of ketoprofen gel product: the type of gelling agent followed by the concentration of the gelling agent, while the IPA concentration has the least effect (in the investigated range). Comparison of release profiles of the investigated formulations of carbomer gels did not show significant effect of the varied factors (concentration of the gelling agent and IPA) on ketoprofen release., Poslednjih godina se sve više pažnje posvećuje razvoju i karakterizaciji podloga kao nosača lekovitih supstanci (aktivni farmaceutski sastojak, eng. API) u farmaceutskim oblicima polučvrste konzistencije za primenu na koži ili sluzokoži. S obzirom da ispitivanja novih lekovitih supstanci zahtevaju velika ulaganja i dugo traju, jedan od pristupa unapređenja terapije bolesti kože, sluzokože ili bolova u mišićima i zglobovima, usmeren je ka modifikaciji postojećih podloga i razvoju i karakterizaciji novih nosača lekovitih supstanci. Cilj rada je bio da se ispita uticaj variranja različitih faktora formulacije kao što su tip i koncentracija sredstva za geliranje, koncentracija izopropil alkohola (IPA) kao rastvarača i 'pojačivača'/inhensera penetracije, fizičkohemijske karakteristike uzoraka aktivne supstance (ketoprofen), nabavljenih od različitih proizvođača, na osobine i stabilnost hidrofilnog gela sa 2,5% (m/m) ketoprofena. Karakterizacija pripremljenih uzoraka ketoprofen gela sprovedena je kroz fizičkohemijska i biofarmaceutska ispitivanja i ispitivanje stabilnosti. Dobijeni rezultati ukazuju na zadovoljavajuću stabilnost ispitivanih uzoraka, kao i na to da faktori formulacije koji ispoljavaju najveći uticaj na fizičkohemijske karakteristike preparata ketoprofen gela jesu: tip upotrebljenog gelirajućeg sredstva, zatim koncentracija korišćenog sredstva za geliranje, a najmanji uticaj ima koncentracija IPA (u ispitivanom opsegu). Poređenjem profila oslobađanja lekovite supstance iz ispitivanih formulacija karbomernih gelova, nije zapažen značajan uticaj variranih faktora (koncentracije gelirajućeg sredstva i IPA) na oslobađanje ketoprofena.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "The influence of different formulation factors on physicochemical and biopharmaceutical characteristics of ketoprofen 2,5% gel, Uticaj faktora formulacije na fizičkohemijske i biofarmaceutske karakteristike ketoprofen 2,5% gela",
volume = "60",
number = "6",
pages = "1237-1255",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1443"
}

Jončić-Savić, K., Pešić, J., Rajić, M., Lukić, M., Jakšić, I., Milić, J., Vuleta, G.,& Savić, S.. (2010). The influence of different formulation factors on physicochemical and biopharmaceutical characteristics of ketoprofen 2,5% gel. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 60(6), 1237-1255.
https://hdl.handle.net/21.15107/rcub_farfar_1443

Jončić-Savić K, Pešić J, Rajić M, Lukić M, Jakšić I, Milić J, Vuleta G, Savić S. The influence of different formulation factors on physicochemical and biopharmaceutical characteristics of ketoprofen 2,5% gel. in Arhiv za farmaciju. 2010;60(6):1237-1255.
https://hdl.handle.net/21.15107/rcub_farfar_1443 .

Jončić-Savić, Katarina, Pešić, Jelena, Rajić, Mirjana, Lukić, Milica, Jakšić, Ivana, Milić, Jela, Vuleta, Gordana, Savić, Snežana, "The influence of different formulation factors on physicochemical and biopharmaceutical characteristics of ketoprofen 2,5% gel" in Arhiv za farmaciju, 60, no. 6 (2010):1237-1255,
https://hdl.handle.net/21.15107/rcub_farfar_1443 .

TY  - JOUR
AU  - Jakšić, Ivana
AU  - Lukić, Milica
AU  - Rajić, Mirjana
AU  - Jončić-Savić, Katarina
AU  - Radulović, Vesna
AU  - Milić, Jela
AU  - Savić, Snežana
PY  - 2010
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1428
AB  - A growing interest in natural surfactants characterized as skin- and environmentfriendly has been observed recently, especially in a group of alkyl polyglucoside (APG) emulsifiers, comprised of natural-origin sugar units and fatty alcohol. The aim of this study was to evaluate the potential of a natural mixed emulsifier (cetostearyl glukozide&cetostearyl alcohol) as an excipiens for stabilisation of emulsion vehicles for model NSAID drugs. Formulations were kept as simple as possible, in order to assess their use in compounding practice or as so-called ready-to-use vehicles. Taking into consideration poor solubility of many, particularly new drug entities, the addition of isopropyl alcohol as a co-solvent and potential penetration enhancer was varied. Characterization of both active and placebo samples (prior to drug incorporation), was organized in three phases that included physicochemical investigation, preliminary NSAID bioavailability screening and safety profile assessment. Results obtained suggest satisfactory physicochemical stability of investigated simple vehicles based on natural mixed emulsifier, fallowed by an exceptional safety profile. Additionally, emulsion vehicles demonstrated an ability to sustain alcohol phase (10% m/m). It can be concluded that these vehicles present promising tools in preparation of various galenic dermatological preparations.
AB  - Poslednjih godina raste interesovanje za grupu prirodnih emulgatora okarakterisanih kao 'prijatelji kože i životne sredine', pri čemu se posebno izdvojila grupa alkil poliglukozidnih (APG) emulgatora, koji se dobijaju iz šećernih jedinica prirodnog porekla i masnog alkohola. Cilj ove studije bio je da se ispita potencijal prirodnog mešanog emulgatora (cetostearil glukozid i cetostearil alkohol) kao ekscipijensa za stabilizaciju emulzionih nosača za model lekovite supstance iz grupe NSAIL. Izabrane su formulacije kremovanosača jednostavnog sastava, kako bi se ujedno procenila mogućnost primene APG emulgatora da stabilizuju jednostavne tzv. 'ready-to-use' podloge namenjene izradi magistralnih dermatoloških lekova. Imajući u vidu slabu rastvorljivost mnogih, a naročito novosintetisanih lekovitih supstanci, variran je dodatak izopropil alkohola u sastavu podloge, koji bi imao ulogu korastvarača i potencijalnog ubrzivača penetracije. Karakterizacija pripremljenih uzoraka kremova (sa i bez dodatka model NSAILnesteroidnih antiinflamatornih lekova) sprovedena je u tri faze, kojima su obuhvaćena fizičkohemijska i biofarmaceutska ispitivanja i procena bezbednosnog profila model podloga sa APG emulgatorom. Uporedna ispitivanja sprovedena su u odnosu na referentnu, farmakopejsku podlogu (Nejonski hidrofilni krem, DAB 2006). Dobijeni rezultati ukazali su na zadovoljavajuće fizičkohemijske i biofarmaceutske karakteristike ispitanih podloga sa prirodnim mešanim emulgatorom APG tipa, koje su imale povoljan bezbednosni profil. Dodatak izopropil alkohola (10% (m/m)) nije se odrazio na stabilnost i bezbednost primene podloga sa APG emulgatorom. U zavisnosti od inkorporirane lekovite supstance iz grupe NSAIL u ispitivane podloge, uočen je različit uticaj na biofarmaceutska svojstva izrađenih uzoraka kremova.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Phisicochemical characterization and safety evaluation of model vehicles based on alkyl polyglucoside emulsifier for the incorporation of NSAID
T1  - Fizičkohemijska karakterizacija i procena bezbednosti model podloga sa alkil poliglukozidnim emulgatorom za NSAIL
VL  - 60
IS  - 1
SP  - 26
EP  - 47
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1428
ER  - 

@article{
author = "Jakšić, Ivana and Lukić, Milica and Rajić, Mirjana and Jončić-Savić, Katarina and Radulović, Vesna and Milić, Jela and Savić, Snežana",
year = "2010",
abstract = "A growing interest in natural surfactants characterized as skin- and environmentfriendly has been observed recently, especially in a group of alkyl polyglucoside (APG) emulsifiers, comprised of natural-origin sugar units and fatty alcohol. The aim of this study was to evaluate the potential of a natural mixed emulsifier (cetostearyl glukozide&cetostearyl alcohol) as an excipiens for stabilisation of emulsion vehicles for model NSAID drugs. Formulations were kept as simple as possible, in order to assess their use in compounding practice or as so-called ready-to-use vehicles. Taking into consideration poor solubility of many, particularly new drug entities, the addition of isopropyl alcohol as a co-solvent and potential penetration enhancer was varied. Characterization of both active and placebo samples (prior to drug incorporation), was organized in three phases that included physicochemical investigation, preliminary NSAID bioavailability screening and safety profile assessment. Results obtained suggest satisfactory physicochemical stability of investigated simple vehicles based on natural mixed emulsifier, fallowed by an exceptional safety profile. Additionally, emulsion vehicles demonstrated an ability to sustain alcohol phase (10% m/m). It can be concluded that these vehicles present promising tools in preparation of various galenic dermatological preparations., Poslednjih godina raste interesovanje za grupu prirodnih emulgatora okarakterisanih kao 'prijatelji kože i životne sredine', pri čemu se posebno izdvojila grupa alkil poliglukozidnih (APG) emulgatora, koji se dobijaju iz šećernih jedinica prirodnog porekla i masnog alkohola. Cilj ove studije bio je da se ispita potencijal prirodnog mešanog emulgatora (cetostearil glukozid i cetostearil alkohol) kao ekscipijensa za stabilizaciju emulzionih nosača za model lekovite supstance iz grupe NSAIL. Izabrane su formulacije kremovanosača jednostavnog sastava, kako bi se ujedno procenila mogućnost primene APG emulgatora da stabilizuju jednostavne tzv. 'ready-to-use' podloge namenjene izradi magistralnih dermatoloških lekova. Imajući u vidu slabu rastvorljivost mnogih, a naročito novosintetisanih lekovitih supstanci, variran je dodatak izopropil alkohola u sastavu podloge, koji bi imao ulogu korastvarača i potencijalnog ubrzivača penetracije. Karakterizacija pripremljenih uzoraka kremova (sa i bez dodatka model NSAILnesteroidnih antiinflamatornih lekova) sprovedena je u tri faze, kojima su obuhvaćena fizičkohemijska i biofarmaceutska ispitivanja i procena bezbednosnog profila model podloga sa APG emulgatorom. Uporedna ispitivanja sprovedena su u odnosu na referentnu, farmakopejsku podlogu (Nejonski hidrofilni krem, DAB 2006). Dobijeni rezultati ukazali su na zadovoljavajuće fizičkohemijske i biofarmaceutske karakteristike ispitanih podloga sa prirodnim mešanim emulgatorom APG tipa, koje su imale povoljan bezbednosni profil. Dodatak izopropil alkohola (10% (m/m)) nije se odrazio na stabilnost i bezbednost primene podloga sa APG emulgatorom. U zavisnosti od inkorporirane lekovite supstance iz grupe NSAIL u ispitivane podloge, uočen je različit uticaj na biofarmaceutska svojstva izrađenih uzoraka kremova.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Phisicochemical characterization and safety evaluation of model vehicles based on alkyl polyglucoside emulsifier for the incorporation of NSAID, Fizičkohemijska karakterizacija i procena bezbednosti model podloga sa alkil poliglukozidnim emulgatorom za NSAIL",
volume = "60",
number = "1",
pages = "26-47",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1428"
}

Jakšić, I., Lukić, M., Rajić, M., Jončić-Savić, K., Radulović, V., Milić, J.,& Savić, S.. (2010). Phisicochemical characterization and safety evaluation of model vehicles based on alkyl polyglucoside emulsifier for the incorporation of NSAID. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 60(1), 26-47.
https://hdl.handle.net/21.15107/rcub_farfar_1428

Jakšić I, Lukić M, Rajić M, Jončić-Savić K, Radulović V, Milić J, Savić S. Phisicochemical characterization and safety evaluation of model vehicles based on alkyl polyglucoside emulsifier for the incorporation of NSAID. in Arhiv za farmaciju. 2010;60(1):26-47.
https://hdl.handle.net/21.15107/rcub_farfar_1428 .

Jakšić, Ivana, Lukić, Milica, Rajić, Mirjana, Jončić-Savić, Katarina, Radulović, Vesna, Milić, Jela, Savić, Snežana, "Phisicochemical characterization and safety evaluation of model vehicles based on alkyl polyglucoside emulsifier for the incorporation of NSAID" in Arhiv za farmaciju, 60, no. 1 (2010):26-47,
https://hdl.handle.net/21.15107/rcub_farfar_1428 .

TY  - JOUR
AU  - Ibrić, Svetlana
AU  - Parojčić, Jelena
AU  - Jakšić, Ivana
AU  - Đurić, Zorica
PY  - 2008
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1148
AB  - Contemporary trends in dosage form development for cardiovascular therapeutics are orientated toward rationalization and individualization of drug administration with the achievement of good compliance. Therefore, novelties in formulation development of cardiovascular drugs are directed towards the modified drug delivery systems. There is a number and variety of new technologies employed with this respect. In the present paper, and overview of the most important technologies applied in commercially available drug products within the group of cardiovascular drugs is given, such as extended release tablets/capsules, multiparticulate drug delivery systems, pulsatile drug delivery and OrosTM technology.
AB  - Savremen farmaceutsko-tehnološki pristup formulaciji preparata u terapiji kardiovaskularnih oboljenja vezan je, pre svega, za individualizaciju i racionalizaciju terapije uz obezbeđenje dobre prihvatljivosti od strane pacijenta i smanjenje neželjenih efekata. U skladu sa tim, novine u formulaciji farmaceutskih oblika sa kardiovaskularnim lekovima odnose se, uglavnom, na razvoj novih, 'naprednih' terapijskih sistema, tj. preparata sa modifikovanim oslobađanjem lekovite supstance. U radu je dat je pregled tehnologija zastupljenih u komercijalno dostupnim preparatima koji se koriste u terapiji kardiovaskularnih oboljenja, s posebnim osvrtom na tablete/kapsule sa modifikovanim oslobađanjem, višečestične terapijske sisteme, preparate sa pulsnim oslobađanjem lekovite supstance i OrosTM terapijske sisteme.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Novelties in dosage form design of the cardiovascular drugs
T1  - Farmaceutsko-tehnološki aspekti savremenih kardiovaskularnih lekova
VL  - 58
IS  - 5-6
SP  - 432
EP  - 442
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1148
ER  - 

@article{
author = "Ibrić, Svetlana and Parojčić, Jelena and Jakšić, Ivana and Đurić, Zorica",
year = "2008",
abstract = "Contemporary trends in dosage form development for cardiovascular therapeutics are orientated toward rationalization and individualization of drug administration with the achievement of good compliance. Therefore, novelties in formulation development of cardiovascular drugs are directed towards the modified drug delivery systems. There is a number and variety of new technologies employed with this respect. In the present paper, and overview of the most important technologies applied in commercially available drug products within the group of cardiovascular drugs is given, such as extended release tablets/capsules, multiparticulate drug delivery systems, pulsatile drug delivery and OrosTM technology., Savremen farmaceutsko-tehnološki pristup formulaciji preparata u terapiji kardiovaskularnih oboljenja vezan je, pre svega, za individualizaciju i racionalizaciju terapije uz obezbeđenje dobre prihvatljivosti od strane pacijenta i smanjenje neželjenih efekata. U skladu sa tim, novine u formulaciji farmaceutskih oblika sa kardiovaskularnim lekovima odnose se, uglavnom, na razvoj novih, 'naprednih' terapijskih sistema, tj. preparata sa modifikovanim oslobađanjem lekovite supstance. U radu je dat je pregled tehnologija zastupljenih u komercijalno dostupnim preparatima koji se koriste u terapiji kardiovaskularnih oboljenja, s posebnim osvrtom na tablete/kapsule sa modifikovanim oslobađanjem, višečestične terapijske sisteme, preparate sa pulsnim oslobađanjem lekovite supstance i OrosTM terapijske sisteme.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Novelties in dosage form design of the cardiovascular drugs, Farmaceutsko-tehnološki aspekti savremenih kardiovaskularnih lekova",
volume = "58",
number = "5-6",
pages = "432-442",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1148"
}

Ibrić, S., Parojčić, J., Jakšić, I.,& Đurić, Z.. (2008). Novelties in dosage form design of the cardiovascular drugs. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 58(5-6), 432-442.
https://hdl.handle.net/21.15107/rcub_farfar_1148

Ibrić S, Parojčić J, Jakšić I, Đurić Z. Novelties in dosage form design of the cardiovascular drugs. in Arhiv za farmaciju. 2008;58(5-6):432-442.
https://hdl.handle.net/21.15107/rcub_farfar_1148 .

Ibrić, Svetlana, Parojčić, Jelena, Jakšić, Ivana, Đurić, Zorica, "Novelties in dosage form design of the cardiovascular drugs" in Arhiv za farmaciju, 58, no. 5-6 (2008):432-442,
https://hdl.handle.net/21.15107/rcub_farfar_1148 .

TY  - JOUR
AU  - Vuleta, Gordana
AU  - Jakšić, Ivana
AU  - Lukić, Milica
AU  - Savić, Snežana
PY  - 2008
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1155
AB  - In our country, boric acid is traditionally used in pharmaceutical preparations for application to the skin, intended for both adults and children. It is used in eye drops as an ingredient of boric buffer and an isotonising agent, in ear drops and some pharmaceutical forms for vaginal application, for the treatment of vulvovaginal candidiasis. However, in some countries there is a tendency not to use boric acid in pharmaceutical preparations for the skin. Furthermore, it is not to be used for children under 3 years of age, since there are evidences of its significant percutaneous absorption and systemic toxicity, upon its application in treatment of large areas of damaged skin. In EU, the use of boric acid and its salts in cosmetic products is regulated through Cosmetics Directive 76/768/EEC and its adaptations. Boric acid, borates and tetraborates are listed in Anex III, a list of substances which cosmetic products must not contain except subject to certain restrictions and conditions.
AB  - Borna kiselina se u našoj zemlji tradicionalno koristi u farmaceutskim preparatima za primenu na koži, namenjenim za odrasle i decu. Koristi se u kapima za oči kao sastojak boratnog pufera i sredstvo za izotonizaciju, u kapima za uši i nekim farmaceutskim oblicima za vaginalnu primenu u tretmanu vulvovaginalne kandidijaze. Međutim, u nekim zemljama postoji tendencija da se borna kiselina ne koristi u farmaceutskim preparatima za kožu. Njena primena zabranjena je kod dece mlađe od tri godine, s obzirom da postoje dokazi da primena preparata sa bornom kiselinom na veću površinu, naročito oštećenu dečiju kožu, može da dovede do značajne perkutane resorpcije i sistemske toksičnosti. U zemljama Evropske Unije, primena borne kiseline i njenih soli u kozmetičkim proizvodima zakonski je regulisana Kozmetičkom direktivom (Cosmetics Directive 76/768/EEC) i njenim dopunama. Borna kiselina, borati i tetraborati nalaze se u Aneksu III koji predstavlja listu supstanci koje se u kozmetičkim proizvodima ne smeju naći, osim pod određenim uslovima i ograničenjima.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Boric acid: Is there a good reason for use in pharmaceutical preparations and cosmetic products?
T1  - Primena borne kiseline u farmaceutskim preparatima i kozmetičkim proizvodima - da ili ne?
VL  - 58
IS  - 4
SP  - 241
EP  - 251
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1155
ER  - 

@article{
author = "Vuleta, Gordana and Jakšić, Ivana and Lukić, Milica and Savić, Snežana",
year = "2008",
abstract = "In our country, boric acid is traditionally used in pharmaceutical preparations for application to the skin, intended for both adults and children. It is used in eye drops as an ingredient of boric buffer and an isotonising agent, in ear drops and some pharmaceutical forms for vaginal application, for the treatment of vulvovaginal candidiasis. However, in some countries there is a tendency not to use boric acid in pharmaceutical preparations for the skin. Furthermore, it is not to be used for children under 3 years of age, since there are evidences of its significant percutaneous absorption and systemic toxicity, upon its application in treatment of large areas of damaged skin. In EU, the use of boric acid and its salts in cosmetic products is regulated through Cosmetics Directive 76/768/EEC and its adaptations. Boric acid, borates and tetraborates are listed in Anex III, a list of substances which cosmetic products must not contain except subject to certain restrictions and conditions., Borna kiselina se u našoj zemlji tradicionalno koristi u farmaceutskim preparatima za primenu na koži, namenjenim za odrasle i decu. Koristi se u kapima za oči kao sastojak boratnog pufera i sredstvo za izotonizaciju, u kapima za uši i nekim farmaceutskim oblicima za vaginalnu primenu u tretmanu vulvovaginalne kandidijaze. Međutim, u nekim zemljama postoji tendencija da se borna kiselina ne koristi u farmaceutskim preparatima za kožu. Njena primena zabranjena je kod dece mlađe od tri godine, s obzirom da postoje dokazi da primena preparata sa bornom kiselinom na veću površinu, naročito oštećenu dečiju kožu, može da dovede do značajne perkutane resorpcije i sistemske toksičnosti. U zemljama Evropske Unije, primena borne kiseline i njenih soli u kozmetičkim proizvodima zakonski je regulisana Kozmetičkom direktivom (Cosmetics Directive 76/768/EEC) i njenim dopunama. Borna kiselina, borati i tetraborati nalaze se u Aneksu III koji predstavlja listu supstanci koje se u kozmetičkim proizvodima ne smeju naći, osim pod određenim uslovima i ograničenjima.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Boric acid: Is there a good reason for use in pharmaceutical preparations and cosmetic products?, Primena borne kiseline u farmaceutskim preparatima i kozmetičkim proizvodima - da ili ne?",
volume = "58",
number = "4",
pages = "241-251",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1155"
}

Vuleta, G., Jakšić, I., Lukić, M.,& Savić, S.. (2008). Boric acid: Is there a good reason for use in pharmaceutical preparations and cosmetic products?. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 58(4), 241-251.
https://hdl.handle.net/21.15107/rcub_farfar_1155

Vuleta G, Jakšić I, Lukić M, Savić S. Boric acid: Is there a good reason for use in pharmaceutical preparations and cosmetic products?. in Arhiv za farmaciju. 2008;58(4):241-251.
https://hdl.handle.net/21.15107/rcub_farfar_1155 .

Vuleta, Gordana, Jakšić, Ivana, Lukić, Milica, Savić, Snežana, "Boric acid: Is there a good reason for use in pharmaceutical preparations and cosmetic products?" in Arhiv za farmaciju, 58, no. 4 (2008):241-251,
https://hdl.handle.net/21.15107/rcub_farfar_1155 .